Creative BioMart has announced a major expansion of its cytokine product collection, providing researchers in immunology, inflammation, and biomedical fields with broader access to essential recombinant proteins. Cytokines are small proteins that serve as intercellular messengers within the immune system, regulating cellular processes in response to infection, injury, and tumors by activating, proliferating, differentiating, and migrating immune cells.
The expanded catalog now includes a diverse range of high-quality recombinant proteins across major functional categories. These include interleukins such as IL-2, IL-6, and IL-10, chemokines like CXCL1 and CCL2, interferons including IFN-α and IFN-γ, and tumor necrosis factor proteins such as TNF-α. The company also offers customization options, allowing researchers to request specific cytokines or formulations tailored to their experimental needs, including variations in protein segments, length, tags, and tag placement.
Featured products in the updated collection include Recombinant Human CXCL10 protein, Recombinant Human IFNA2 protein, Active Recombinant Human NGF protein, Recombinant Mouse chemokine (C-C motif) ligand 7 (CCL7), Active Recombinant Human Interferon Gamma Receptor 1, Fc Chimera, and Active Recombinant Human TNFSF8, Fc tagged. Researchers can explore the complete updated cytokine portfolio at https://www.creativebiomart.net/gene-family-11-cytokines.htm.
"Cytokines play a central role in shaping immune responses, and access to well-characterized proteins is essential for experimental design," stated Linna, chief marketing staff at Creative BioMart. "We are certain that our expanded products will help to change our understanding of human health and illness while also improving patient outcomes." According to Linna, the structured portfolio enables systematic research of immune signaling and inflammation pathways by categorizing proteins into functional families and offering relevant receptor-targeted items.
The expansion has significant implications for the biotechnology and pharmaceutical industries. By providing easier access to a wider range of cytokines, Creative BioMart enables researchers to design more comprehensive experiments, compare data across multiple cytokines, and integrate complementary reagents more effectively. This could accelerate discoveries in autoimmune diseases, cancer immunotherapy, infectious disease responses, and chronic inflammatory conditions.
Beyond cytokines, Creative BioMart also provides cytokine receptor proteins and receptor-binding variants, facilitating investigation of receptor-ligand interactions and functional experiments. This comprehensive approach supports the growing demand for precision tools in immunology research, where understanding specific signaling pathways is crucial for developing targeted therapies. The expanded collection represents a strategic investment in research infrastructure that could reduce experimental barriers and shorten development timelines for new treatments.
